FAST Conference Draws 20 Pharmaceutical Companies and Raises Over $2.2 Million for Research on Angelman Syndrome

FAST (the Foundation for Angelman Syndrome Therapeutics) today announced that Virtually Unstoppable, their annual Summit & Gala benefitting Angelman syndrome (AS) raised over $2.2 million during their virtual two-day conference.
14-Dec-2020 9:15 AM EST Add to Favorites

Penn Gene Therapy Pioneer Teams Up with FAST in Race to Cure Angelman Syndrome

A pioneer on the frontier of genetic medicine and his team at one of the nation’s top-five medical research schools have joined forces with FAST (Foundation for Angelman Syndrome Therapeutics) to develop a treatment for the rare disorder Angelman...
14-Feb-2017 3:05 PM EST Add to Favorites